human
be
constantli
expos
myriad
pathogen
includ
bacteria
fungi
virus
foreign
invad
cohabit
contain
molecular
structur
sens
innat
immun
system
mount
firstlin
defens
also
activ
pathogenspecif
adapt
immun
respons
adapt
immun
system
compos
b
cell
produc
specif
antibodi
cell
kill
pathogeninfect
cell
cell
produc
effector
cytokin
coordin
immun
respons
cell
express
antigen
receptor
tcell
antigen
receptor
tcr
recogn
specif
peptid
present
mhc
molecul
cell
recogn
peptid
present
mhc
classi
molecul
ubiquit
express
wherea
cell
activ
peptidemhc
classii
complex
larg
restrict
antigenpres
cell
apc
dendrit
cell
dc
express
high
level
mhc
costimulatori
molecul
gener
accept
relev
cell
induc
activ
prime
antigenspecif
naiv
cell
induc
differenti
variou
type
effector
cell
elimin
contain
differ
type
pathogen
requir
dedic
class
adapt
immun
respons
thu
pathogen
like
virus
intracellular
bacteria
requir
cell
produc
kill
infect
cell
ctl
respect
critic
cytokin
induc
type
respons
product
dc
tightli
control
requir
sever
stimuli
deriv
pathogen
helper
cell
convers
extracellular
bacteria
fungi
requir
differ
type
respons
mediat
cell
effector
cell
induc
proinflammatori
cytokin
produc
dc
macrophag
attract
neutrophil
turn
phagocytos
extracellular
bacteria
third
type
effector
respons
respons
requir
expel
extracellular
parasit
helminth
activ
eosinophil
basophil
induc
antibodi
ige
class
critic
cytokin
induc
respons
normal
produc
dc
final
differ
effector
respons
control
special
regulatori
cell
particular
cell
cell
gener
effector
cell
import
avoid
excess
tissu
damag
adapt
immun
respons
cytokin
promot
type
regulatori
tcell
respons
cytokin
produc
dc
profession
apc
present
pathogenderiv
peptid
mhc
molecul
activ
antigenspecif
cell
dc
phagocyt
immatur
state
ie
steadyst
condit
upon
initi
pathogen
encount
take
antigen
materi
pinocytosi
surfac
receptormedi
intern
protein
pathogen
shuttl
lysosom
chop
peptid
load
mhc
classii
molecul
complex
transport
plasma
membran
activ
specif
cell
present
peptid
deriv
exogen
protein
mhc
classi
process
call
crosspresent
larg
uniqu
featur
dc
particularli
import
activ
cell
viral
infect
virusinfect
cell
express
viral
protein
cytosol
degrad
peptid
proteasom
transloc
endoplasm
reticulum
tap
protein
load
mhc
classi
molecul
howev
sinc
dc
necessarili
infect
virus
must
abl
process
virusderiv
protein
also
extern
sourc
virusinfect
cell
activ
cell
mechan
crosspresent
still
incomplet
understood
two
distinct
pathway
via
vacuol
peptid
transloc
phagolysosom
cytosol
describ
believ
crosspresent
import
pathway
lead
induct
cytotox
tcell
respons
excel
review
publish
relev
topic
naiv
cell
high
activ
threshold
profession
apc
express
high
level
mhc
costimulatori
molecul
dc
abl
induc
prolifer
naiv
cell
sever
interact
contribut
naiv
tcell
activ
costimul
particularli
import
amplifi
signal
transduc
tcr
monocyt
effici
present
peptid
deriv
extracellular
protein
mhc
classii
activ
antigenexperienc
cell
capac
exploit
select
expand
antigenspecif
memori
cell
howev
monocyt
approxim
lower
capac
prime
naiv
cell
compar
dc
nizzoli
et
al
review
home
nonlymphoid
tissu
steadi
state
howev
upon
inflamm
differenti
inflammatori
dc
home
lymph
node
activ
cell
addit
evid
subset
human
blood
monocyt
might
contain
dc
naiv
cell
constantli
recircul
blood
migrat
secondari
lymphoid
organ
larg
exclud
nonlymphoid
tissu
secondari
lymphoid
tissu
migrat
tcell
zone
encount
dc
b
cell
also
present
secondari
lymphoid
organ
potent
present
antigen
cell
intern
process
antigen
specif
bound
bcell
receptor
howev
b
cell
physic
separ
naiv
cell
lymph
node
follow
tcr
activ
naiv
cell
migrat
bcell
zone
interact
antigenspecif
b
cell
induc
antibodi
product
thu
antigen
present
b
cell
appear
import
activ
antigenexperienc
cell
rather
naiv
tcell
prime
dendrit
cell
gener
commit
precursor
bone
marrow
releas
circul
seed
peripher
organ
monocyt
dc
deriv
common
myeloid
progenitor
cmp
commit
precursor
select
give
rise
monocyt
dc
even
select
dc
subset
identifi
human
mice
dc
poorli
stimulatori
immatur
state
induc
partial
tcell
activ
lead
delet
autoreact
cell
addit
promot
selftoler
induc
regulatori
cell
suppress
autoreact
cell
pathogen
induc
matur
dc
consequ
acquir
capac
produc
polar
cytokin
prime
pathogenspecif
effector
tcell
respons
pathogenderiv
molecular
pattern
pamp
recogn
dc
lead
effici
present
antigen
cell
differ
class
pathogensens
receptor
includ
tolllik
receptor
nucleotidebind
oligomer
domain
nod
like
receptor
retino
acidinduc
gene
rigi
like
receptor
ctype
lectin
tlr
recogn
differ
pamp
includ
nucleic
acid
cell
wall
compon
protein
lipoprotein
case
virus
nucleic
acid
sens
differ
tlr
endosom
also
cytosol
receptor
like
rigi
induc
potent
activ
dc
importantli
subset
dc
express
differ
pattern
pathogensens
receptor
might
thu
preferenti
respond
individu
pathogen
dna
virus
cytomegaloviru
cmv
herp
simplex
viru
hsv
also
bacteria
activ
dc
via
unmethyl
cpgcontain
dna
sens
doubl
singlestrand
rna
gener
dna
rna
virus
sens
dc
via
respect
note
restrict
mdc
induc
crosspresent
capac
virus
respiratori
syncyti
viru
rsv
hepat
c
viru
hcv
also
activ
dc
via
express
plasma
membran
recogn
viral
protein
also
involv
immun
respons
fungi
gramposit
bacteria
recogn
lipopolysaccharid
lp
cell
membran
compound
gramneg
bacteria
mani
pathogen
like
virus
activ
dc
via
multipl
tlr
moreov
immun
cell
includ
cell
feedback
dc
regul
ongo
respons
particular
stimul
helper
cell
crucial
tcell
stimul
product
moreov
paradox
also
provid
cell
enhanc
product
surfac
tlr
signal
via
adaptor
protein
induc
activ
map
kinas
nuclear
transloc
transcript
factor
turn
induc
transcript
proinflammatori
cytokin
endosom
tlr
also
signal
via
activ
turn
induc
interferon
product
except
sinc
signal
via
util
trif
activ
complex
signal
pathway
integr
dc
induc
appropri
tcell
respons
still
incomplet
understood
dendrit
cell
mice
subdivid
distinct
subset
specif
function
dc
stabli
resid
lymph
node
other
posit
nonlymphoid
tissu
sens
tissueinvad
pathogen
migratori
recruit
via
lymph
follow
pathogen
encount
manner
secondari
lymphoid
tissu
two
major
dc
subset
myeloid
dc
mdc
plasmacytoid
dc
pdc
tabl
pdc
mdc
upregul
mhc
costimulatori
molecul
like
upon
matur
bind
requir
induc
full
tcell
stimul
howev
pdc
poorli
phagocyt
differ
regul
mhc
classii
turnov
upon
matur
compar
mdc
thu
mdc
stop
phagocytosi
peptid
load
mhc
upon
pathogen
recognit
stabli
present
peptid
antigen
materi
acquir
upon
pathogen
encount
maturationinduc
stabil
complex
enhanc
prime
pathogenspecif
cell
mdc
contrast
pdc
continu
present
new
peptid
mhc
complex
even
matur
stage
one
hand
limit
capac
stimul
pathogenspecif
cell
hand
enabl
present
also
lateexpress
viral
antigen
activ
infect
divers
regul
stabil
mdc
pdc
suggest
present
differ
antigen
cell
plasmacytoid
dc
present
lymph
node
larg
absent
nonlymphoid
organ
recruit
upon
inflamm
role
pdc
tcell
prime
still
debat
consensu
poorli
stimulatori
rest
state
group
propos
becom
potent
apc
follow
tlr
stimul
prime
crossprim
tcell
respons
other
conclud
also
matur
pdc
low
prime
crossprim
capac
might
rather
tolerogen
rapid
abund
product
interferon
pdc
suggest
pivot
role
viral
infect
even
capac
prime
virusspecif
cell
directli
appear
limit
also
produc
immun
cell
virusinfect
cell
earli
system
respons
believ
depend
pdc
consist
case
hsv
infect
shown
pdc
import
system
local
protect
howev
sever
viral
infect
mice
includ
vesicular
stomat
viru
vsv
lymphocyt
choriomening
viru
lcmv
rsv
mous
cytomegaloviru
mcmv
pdc
seem
play
major
role
mark
contrast
mous
hepat
viru
mhv
infect
antivir
respons
coronaviru
larg
pdc
depend
figur
final
pdc
found
sever
group
induc
product
antiinflammatori
cytokin
cell
suggest
might
import
inhibit
excess
tcell
respons
sever
protein
express
pdc
found
promot
induct
cell
includ
notch
ligand
deltalik
icosl
well
nizzoli
et
al
review
myeloid
dc
heterogen
popul
differ
mdc
subset
identifi
preferenti
initi
differ
type
adapt
immun
respons
figur
spleen
mice
mdc
subdivid
subset
tabl
mdc
produc
high
level
bioactiv
effici
crossprim
tcell
respons
express
ctype
lectin
enabl
take
antigen
materi
die
cell
gener
shown
reli
transcript
factor
moreov
express
chemokin
receptor
favor
coloc
cell
altogeth
present
evid
indic
dc
special
induc
ctl
respons
respons
intracellular
pathogen
notabl
dc
gut
express
similar
characterist
close
relat
dc
dc
express
subdivid
subset
preferenti
prime
tcell
respons
promot
respons
also
induc
cell
interestingli
dc
produc
gut
requir
protect
citrobact
rodentium
gener
depend
transcript
factor
express
requir
induct
notabl
howev
dc
also
pdc
crossprim
tcell
respons
certain
condit
moreov
shown
upon
appropri
microbi
stimul
mdc
subset
potenti
promot
either
respons
thu
although
propos
function
special
dc
subset
intrigu
help
concept
might
also
oversimplif
sinc
dc
subset
consider
plastic
induct
specif
type
immun
respons
critic
depend
stimuli
receiv
pathogen
well
immun
cell
high
number
human
dc
gener
vitro
cultur
monocyt
cytokin
larg
major
studi
human
dc
done
monocytederiv
dc
primari
cell
show
mani
behavior
vivo
occur
dc
includ
cytokin
product
well
stabl
potent
antigen
present
upon
matur
tlr
ligand
howev
monocytederiv
dc
appropri
model
studi
role
special
dc
subset
human
immun
respons
dendrit
cell
circul
low
frequenc
human
peripher
blood
share
sever
featur
murin
splenic
dc
subset
tabl
human
pdc
identifi
year
ago
natur
cell
express
produc
larg
amount
respons
cpg
dna
influenza
viru
similar
murin
counterpart
poorli
stimulatori
express
ctype
lectin
induc
product
cell
addit
subset
mdc
also
found
human
blood
tissu
murin
homologu
express
potent
prime
tcell
respons
express
identifi
two
subset
among
human
mdc
peripher
blood
also
secondari
lymphoid
organ
tabl
rare
could
recent
demonstr
repres
human
counterpart
murin
dc
thu
dc
select
express
depend
transcript
factor
importantli
crosspres
exogen
antigen
mhc
classi
cell
produc
tabl
frequent
share
featur
dc
includ
express
product
nizzoli
et
al
review
also
express
dc
subset
appear
similar
human
mice
sinc
express
high
level
dc
lower
level
dc
absent
pdc
surprisingli
mice
requir
immun
respons
sever
virus
includ
lcmv
vsv
mcmv
reoviru
suggest
pivot
role
antivir
immun
defens
consist
defici
human
select
lead
uncontrol
infect
central
nervou
system
cn
differ
subset
dc
also
identifi
human
nonlymphoid
tissu
strateg
posit
recogn
invad
pathogen
particular
barrier
surfac
migratori
dc
subset
play
crucial
role
transport
antigen
materi
pathogen
invad
specif
tissu
drain
lymph
node
thu
initi
tissuespecif
tcell
respons
human
langerhan
cell
first
describ
centuri
ago
resid
epidermi
thu
first
dc
encount
skininvad
pathogen
upon
activ
matur
migrat
drain
lymph
node
activ
cell
dermi
differ
subset
interstiti
dc
present
classifi
accord
express
dermal
cell
might
repres
monocytederiv
macrophag
rather
dc
dc
respect
resembl
dc
subset
peripher
blood
also
lung
liver
dc
subset
relat
dc
could
identifi
final
human
intestin
dc
subset
express
similar
dc
respect
intestin
dc
subset
also
larg
conserv
human
mice
although
similar
human
mous
dc
subset
often
emphas
also
import
differ
pathogen
sens
dc
human
mice
importantli
express
sever
relev
tlr
conserv
figur
presum
human
mice
evolv
select
pressur
differ
pathogen
thu
mice
express
pdc
mdc
subset
wherea
human
restrict
pdc
also
express
restrict
human
dc
sinc
express
moreov
express
human
pdc
agonist
human
resiquimod
activ
murin
anoth
relev
differ
seem
role
adaptor
protein
transduc
signal
tlr
notabl
except
thu
mice
defici
highli
suscept
sever
infect
bacteria
virus
parasit
fungi
convers
patient
select
affect
infect
pyogen
bacteria
childhood
final
human
dc
also
langerhan
cell
seem
superior
capac
crosspres
antigen
induc
ctl
respons
compar
murin
homologu
overal
differ
pathogen
sens
tcell
activ
human
murin
dc
like
import
impact
role
immun
respons
specif
pathogen
dendrit
cell
subset
human
mice
express
differ
pattern
tolllik
receptor
also
partial
distinct
cytokin
profil
figur
particular
human
complex
quit
uniqu
regul
cytokin
product
thu
lp
trigger
low
level
cytokin
product
dual
tlr
stimul
lp
polyi
c
ligand
combin
induc
high
level
broad
panel
cytokin
includ
tnf
nizzoli
et
al
review
potent
cytokineproduc
capac
miss
sever
studi
activ
singl
tlr
ligand
note
singl
tlr
stimul
suffici
induc
antivir
cytokin
pdc
see
proinflammatori
cytokin
monocyt
although
secret
sever
proinflammatori
cytokin
promot
cell
gener
includ
unclear
physiolog
induc
cell
monocytederiv
inflammatori
dc
job
also
ident
dc
subset
induc
human
respons
still
enigmat
origin
propos
mdc
induc
polar
pdc
later
shown
also
pdc
drive
respons
recent
found
induc
cell
aberr
respons
influenza
viru
appar
contrast
dc
produc
high
level
suggest
relev
role
immun
respons
intracellular
pathogen
moreov
product
antiinflammatori
cytokin
produc
mdc
mice
larg
restrict
human
nizzoli
et
al
review
stimul
intestin
bacterium
escherichia
coli
lp
alon
induc
propos
induc
tolerogen
state
although
inde
tolerogen
cytokin
wellestablish
neg
regul
dc
matur
cytokin
product
paradox
also
posit
effect
particular
tcell
respons
consist
found
produc
complet
block
crossprim
lowaffin
ctl
enhanc
respons
memori
cell
homeostat
cytokin
thu
appear
play
import
posit
role
ctl
respons
sinc
select
high
affin
cell
upon
prime
inhibit
ctl
memori
attrit
time
nizzoli
et
al
review
secret
broad
panel
pro
antiinflammatori
cytokin
pdc
larg
dedic
secret
high
level
antivir
cytokin
subsetspecif
product
pdc
appear
larg
conserv
human
mice
potent
capac
dc
suggest
analog
pdc
might
relev
sourc
earli
system
viral
infect
notabl
antiprolif
antivir
activ
similar
typei
interferon
express
receptor
much
restrict
found
mainli
epitheli
cell
barrier
surfac
liver
also
secret
select
isoform
consist
view
play
import
role
antivir
immun
respons
previous
mention
murin
pdc
power
antivir
cytokin
activ
sever
differ
type
immun
cell
also
induc
product
cell
suggest
pdc
induc
regulatori
cell
also
human
nizzoli
et
al
review
restrict
express
tlr
specif
cytokineproduc
capac
human
dc
subset
suggest
play
uniqu
role
immun
respons
individu
pathogen
role
human
dc
subset
pathogenspecif
immun
respons
howev
difficult
address
directli
patient
select
lack
dc
subset
interest
identifi
far
nevertheless
interest
find
report
particular
appear
highli
relev
hcv
infect
singlenucleotid
polymorph
gene
locu
strongli
associ
spontan
clearanc
respons
therapi
hcv
patient
dc
subset
secret
produc
much
higher
amount
moreov
larg
restrict
importantli
hcv
induc
product
nizzoli
et
al
review
thu
appear
highli
relev
sourc
protect
hcv
infect
interestingli
import
role
rather
recent
propos
tuberculosi
thu
effici
infect
bacillu
bcg
vaccin
dc
induc
activ
pdc
cell
notabl
could
replac
system
suggest
could
play
nonredund
role
defens
select
intracellular
pathogen
also
suggest
play
differ
role
rsv
infect
thu
mdc
subset
produc
differ
cytokin
respons
rsv
consist
differ
cytokin
profil
upon
stimul
purifi
tlr
ligand
nizzoli
et
al
review
moreov
induc
differ
class
tcell
respons
induc
preferenti
cell
induc
predominantli
tregulatori
cell
similarli
found
induc
respons
influenza
viru
also
capac
pdc
induc
regulatori
cell
document
relev
pathogen
sinc
pdc
shown
induc
product
antigenexperienc
cell
specif
mump
viru
convers
mdc
contain
induc
surprisingli
larg
accept
pdcderiv
import
contain
human
viral
infect
thu
stabil
pegyl
wide
use
therapi
hcv
patient
appear
similar
effect
less
toxic
presum
restrict
express
receptor
interestingli
hcv
glycoprotein
ligand
specif
express
pdc
tabl
inhibit
product
way
hcv
might
inhibit
product
establish
chronic
infect
final
pdc
also
target
human
immunodefici
viru
hiv
whether
play
protect
detriment
role
still
unclear
vaccin
major
breakthrough
human
health
attenu
kill
pathogen
highli
effici
induc
protect
cellular
humor
immun
respons
induc
protect
memori
last
lifetim
howev
sinc
pathogenbas
vaccin
also
consider
side
effect
protein
combin
adjuv
activ
apc
often
use
protein
vaccin
induc
tcell
respons
neutral
antibodi
poorli
effici
induc
cytotox
tcell
respons
also
rather
ineffici
induc
cell
frequent
use
adjuv
alum
oilinwat
emuls
like
recent
also
monophosphoryl
lipid
mpl
detoxifi
form
lp
mice
differ
adjuv
shown
induc
differ
proinflammatori
cytokin
thu
alum
act
via
uric
acid
inflammatori
dc
lead
nodlik
receptor
depend
product
convers
mpl
induc
induc
specif
antibodi
mechan
alum
act
independ
howev
differ
tlr
express
cytokin
product
human
apc
subset
consid
translat
knowledg
anim
model
patient
recent
interest
report
analyz
respons
apc
subset
differ
vaccin
conclud
differ
vaccin
activ
inde
differ
apc
popul
direct
inform
effect
dc
obtain
vaccin
peptidepuls
monocytederiv
dc
cancer
patient
induc
tumorspecif
cell
clinic
respons
far
larg
insuffici
mdc
might
potent
current
test
clinic
trial
nucleic
acidsens
tlr
particularli
potent
induc
tcell
respons
mice
recent
employ
adjuv
vaccin
exampl
cpgdna
stimul
ligand
imiquimod
use
cream
stimul
dc
local
skin
shown
induc
tcell
respons
situ
vaccin
consist
plasmid
dna
code
relev
protein
antigen
novel
approach
effici
induc
humor
cellular
immun
respons
anim
howev
human
dna
vaccin
often
poorli
immunogen
presum
low
adjuv
activ
stimul
mainli
cytosol
dna
sensor
rather
addit
restrict
pdc
b
cell
human
altern
promis
approach
vaccin
mrna
deliv
antigen
protein
directli
cytosol
therebi
bypass
requir
crosspresent
also
induc
mdc
pdc
matur
cytokin
product
via
time
inde
intraderm
inject
nake
mrna
result
local
uptak
translat
nucleic
acid
follow
develop
adapt
immun
mice
human
sinc
also
lymph
noderesid
dc
expect
appropri
apc
process
antigen
encod
mrna
direct
inject
nucleic
acid
lymph
node
also
evalu
anim
model
intralymph
node
inject
mrna
result
express
protein
encod
mrna
dc
furthermor
inject
mrna
activ
lymph
noderesid
apc
induc
potent
tcell
respons
well
prophylact
therapeut
antitumor
immun
approach
current
evalu
two
clinic
studi
explor
efficaci
intralymph
node
mrna
vaccin
advanc
melanoma
patient
develop
system
administr
liposom
formul
mrna
deliv
nucleic
acid
apc
present
secondari
lymphoid
organ
also
evalu
use
function
divers
dc
vivo
specif
capabl
gener
appropri
adapt
immun
respons
system
synthet
vaccin
might
recapitul
natur
mechan
immun
develop
pathogen
infect
guarante
develop
therapeut
efficaci
immun
respons
dendrit
cell
continu
attract
much
interest
immunologist
potent
apc
immun
system
princip
induc
naiv
tcell
differenti
intens
research
last
year
establish
differ
subset
dc
exist
mice
special
function
preferenti
induc
differ
type
immun
respons
human
much
learn
vitro
differenti
monocytederiv
dc
recent
also
differ
subset
dc
popul
human
tissu
analyz
molecular
function
level
fundament
defin
biolog
vivo
occur
human
dc
subset
understand
cure
pathogen
immunemedi
process
differ
set
autoimmun
infect
cancer
particular
appropri
target
dc
subset
vaccin
hold
promis
induc
cytotox
tcell
respons
erad
persist
intracellular
pathogen
tumor
steve
pascolo
founder
ceo
miescher
pharma
gmbh
compani
exploit
immunostimul
potenti
rna
remain
coauthor
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
